Cargando…
GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
BACKGROUND: Glypican 2 (GPC2), a member of glypican (GPC) family genes, produces proteoglycan with a glycosylphosphatidylinositol anchor. It has shown its ascending significance in multiple cancers such as neuroblastoma, malignant brain tumor, and small-cell lung cancer. However, no systematic pan-c...
Autores principales: | Chen, Guoming, Luo, Dongqiang, Zhong, Nan, Li, Danyun, Zheng, Jiyuan, Liao, Hui, Li, Zhuoyao, Lin, Xiaoxiao, Chen, Qiqi, Zhang, Cheng, Lu, Yuanjun, Chan, Yau-Tuen, Ren, Qing, Wang, Ning, Feng, Yibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957202/ https://www.ncbi.nlm.nih.gov/pubmed/35345673 http://dx.doi.org/10.3389/fimmu.2022.857308 |
Ejemplares similares
-
Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions
por: Chen, Guoming, et al.
Publicado: (2023) -
HAMP as a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
por: Chen, Guoming, et al.
Publicado: (2023) -
Clinical Characteristics and Treatment Overview in Hand-Foot-and-Mouth Disease Using Real-World Evidence Based on Hospital Information System
por: Chen, Guoming, et al.
Publicado: (2022) -
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
por: Lu, Yuanjun, et al.
Publicado: (2020) -
Prognostic and immunological role of CD36: A pan-cancer analysis
por: Chen, Yong-Jian, et al.
Publicado: (2021)